drugset / Trial / NCT05177328
Targeted Investigation of Microbiome Elimination
Phase 1
Terminated
21 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis Research Network · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the pharmacokinetics or survival of new product containing commensal infection fighting bacteria, on the skin of patients with Atopic Dermatitis (AD), after a single application.
Timeline
- Start
- 2022-07-18
- Primary completion
- 2023-08-27
- Completion
- 2023-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ShA9 | Other / unclassified | — | Topical |